JZJie Zheng

Jie Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jie Zheng has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    T2 preparation method for measuring hyperemic myocardial O2 consumption: in vivo validation by positron emission tomography

    by Kyle S. McCommis, Robert O'Connor, Dana R. Abendschein, David Muccigrosso, Robert J. Gropler, Jie Zheng

    Purpose To validate a new T2‐prepared method for the quantification of regional myocardial O2 consumption during pharmacologic stress with positron emission tomography (PET). Materials and Methods A T2 prepared gradient‐echo sequence was modified to measure myocardial T2 within a single breath‐hold. Six beagle dogs were randomly selected for the induction of coronary artery stenosis. Magnetic resonance imaging (MRI) experiments were performed with the T2 imaging and first‐pass perfusion imaging at rest and during either dobutamine‐ or dipyridamole‐induced hyperemia. Myocardial blood flow (MBF) was quantified using a previously developed model‐free algorithm. Hyperemic myocardial O2 extraction fraction (OEF) and consumption (MVO2) were calculated using a two‐compartment model developed previously. PET imaging using 11C‐acetate and 15O‐water was performed in the same day to validate OEF, MBF, and MVO2 measurements. Results The T2‐prepared mapping sequence measured regional myocardial T2 with a repeatability of 2.3%. By myocardial segment‐basis analysis, MBF measured by MRI is closely correlated with that measured by PET (R2 = 0.85, n = 22). Similar correlation coefficients were observed for hyperemic OEF (R2 = 0.90, n = 9, mean difference of PET – MRI = −2.4%) and MVO2 (R2 = 0.83, n = 7, mean difference = 4.2%). Conclusion The T2‐prepared imaging method may allow quantitative estimation of regional myocardial oxygenation with relatively good accuracy. The precision of the method remains to be improved. J. Magn. Reson. Imaging 2011;33:320–327.


  • Targeted Contrast Agent Helps to Monitor Advanced Plaque During Progression: A Magnetic Resonance Imaging Study in Rabbits

    by Jie Zheng, Elizabeth Ochoa, Bernd Misselwitz, Deshan Yang, Issam El Naqa, Pamela K. Woodard, Dana Abendschein

    Gadofluorine M has been reported to enhance early atherosclerotic plaque signals in magnetic resonance imaging (MRI). The aim of this study was to examine the use of Gadofluorine M to monitor the progression of advanced plaques in a rabbit model. Focal advanced atherosclerosis was induced in the right femoral arteries of 6 New Zealand white rabbits using a combination of cholesterol-enriched diet, and sequential air-desiccation, and balloon-overstretch injury. MRI with conventional 3 contrasts (T1, T2, and proton density [PD]) was performed to monitor the progression of the atherosclerotic plaques with 2 MRI scans separated by 4 to 8 weeks. Gadofluorine M was given intravenously to the rabbits 24 hours before the first MRI scans, and before (n = 3) or during (n = 3) the second MRI scan. The left femoral arteries were used as a control. Histopathologic images localized individual plaque components. The advanced plaque displayed multilayered neointima that included foam cells, smooth muscle cells, and extracellular matrix. The separate image contrasts offered similar T1-weighted enhancement patterns, but the combination of all 3 contrasts helped to delineate plaque and lumen boundaries. Gadofluorine M strongly enhanced neointima areas with an image contrast (contrast-to-noise ratio [CNR]) of approximately 15, versus 2 in the control femoral arterial wall. With improved images, significant changes in neointima and total plaque volumes over the 4 to 8 weeks between scans could be identified. Gadofluorine M remained within the plaques with significant image enhancements (contrast-to-noise ratio = 5.8) for 2 months after a single injection. This preliminary study in rabbits indicated that Gadofluorine M provides specific enhancements of components associated with advanced atherosclerotic plaques and may help to monitor the progression of the plaque in a rabbit model of atherogenesis.